Julie Smith - Net Worth and Insider Trading
Julie Smith Net Worth
The estimated net worth of Julie Smith is at least $189,323 dollars as of 2024-11-06. Julie Smith is the Director of Exelixis Inc and owns about 5,445 shares of Exelixis Inc (EXEL) stock worth over $189,323. Details can be seen in Julie Smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Julie Smith has not made any transactions after 2024-05-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Julie Smith
Julie Smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Julie Smith owns 4 companies in total, including Stoke Therapeutics Inc (STOK) , Exelixis Inc (EXEL) , and Audentes Therapeutics Inc (BOLD) among others .
Click here to see the complete history of Julie Smith’s form 4 insider trades.
Insider Ownership Summary of Julie Smith
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STOK | Stoke Therapeutics Inc | 2020-06-03 | director |
| EXEL | Exelixis Inc | 2024-05-21 | director |
| BOLD | Audentes Therapeutics Inc | 2020-01-15 | director |
 | | 2016-10-24 | director & President and CEO |
Julie Smith Latest Holdings Summary
Julie Smith currently owns a total of 1 stock. Julie Smith owns 5,445 shares of Exelixis Inc (EXEL) as of May 21, 2024, with a value of $189,323.
Latest Holdings of Julie Smith
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EXEL | Exelixis Inc | 2024-05-21 | 5,445 | 34.77 | 189,323 |
Holding Weightings of Julie Smith
Julie Smith Form 4 Trading Tracker
According to the SEC Form 4 filings, Julie Smith has made a total of 1 transactions in Exelixis Inc (EXEL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Exelixis Inc is the sale of 27,280 shares on May 21, 2024, which brought Julie Smith around $576,154.
Insider Trading History of Julie Smith
- 1
Julie Smith Trading Performance
Julie Smith Ownership Network
Ownership Network List of Julie Smith
Ownership Network Relation of Julie Smith
Julie Smith Owned Company Details
What does Stoke Therapeutics Inc do?
Who are the key executives at Stoke Therapeutics Inc?
Julie Smith is the director of Stoke Therapeutics Inc. Other key executives at Stoke Therapeutics Inc include Chief Medical Officer Barry Ticho , 10 percent owner Skorpios Trust , and COO & CBO Huw M. Nash .
Stoke Therapeutics Inc (STOK) Insider Trades Summary
Over the past 18 months, Julie Smith made no insider transaction in Stoke Therapeutics Inc (STOK). Other recent insider transactions involving Stoke Therapeutics Inc (STOK) include a net sale of 134,116 shares made by Barry Ticho , a net sale of 18,022 shares made by Jonathan Allan , and a net sale of 56,616 shares made by Huw M. Nash .
In summary, during the past 3 months, insiders sold 1,967,500 shares of Stoke Therapeutics Inc (STOK) in total and bought 0 shares, with a net sale of 1,967,500 shares. During the past 18 months, 5,803,870 shares of Stoke Therapeutics Inc (STOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,803,870 shares.
Stoke Therapeutics Inc (STOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Stoke Therapeutics Inc Insider Transactions
Julie Smith Mailing Address
Above is the net worth, insider trading, and ownership report for Julie Smith. You might contact Julie Smith via mailing address: C/o Raptor Pharmaceutical Corp, 9 Commercial Blvd, Suite 200, Novato Ca 94949.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
